potentially moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). This announcement came after the Department of Justice, under the Biden Administration, submitted a proposed rule in May 2024 to begin rescheduling marijuana, sparking renewed attention in Congress, advocacy groups, and the media.
On August 28, nine Republican members of Congress sent a letter to U.S. Attorney General Pam Bondi opposing rescheduling marijuana, warning that it could deliver a multi-billion-dollar tax break to multistate cannabis companies and even to criminal cartels. They argued marijuana lacks accepted medical use, has high abuse potential, and poses risks to children.
In contrast, the Drug Policy Alliance (DPA) is urging the White House not only to support rescheduling marijuana but to fully legalize cannabis at the federal level. The group has launched a petition encouraging President Trump to follow through on rescheduling marijuana from Schedule I to Schedule III, which would recognize accepted medical use and ease the burdens of Section 280E, though cannabis would remain criminalized under federal law.
Copyright
©420 Intel